| scholarly article | Q13442814 |
| P50 | author | Linda A Sherman | Q42403205 |
| Christian J. Maine | Q55089465 | ||
| Gail A Bishop | Q56650269 | ||
| P2093 | author name string | Zuoan Yi | |
| Laura L Stunz | |||
| Wai W Lin | |||
| P2860 | cites work | Subcellular localization of intracellular protein tyrosine phosphatases in T cells | Q24273420 |
| The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3 | Q24292506 | ||
| Identification of a nuclear Stat1 protein tyrosine phosphatase | Q24302061 | ||
| The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity | Q24310219 | ||
| Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6 | Q24317429 | ||
| Large-scale structural analysis of the classical human protein tyrosine phosphatome | Q24321557 | ||
| Principles of interleukin (IL)-6-type cytokine signalling and its regulation | Q24530173 | ||
| Regulation of type I interferon responses | Q26853177 | ||
| Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling | Q27002391 | ||
| Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia | Q28240713 | ||
| High-resolution genomic analysis in Waldenström's macroglobulinemia identifies disease-specific and common abnormalities with marginal zone lymphomas | Q28241121 | ||
| IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase | Q28270103 | ||
| Interleukin-6 family of cytokines and gp130 | Q28295098 | ||
| PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells | Q28590230 | ||
| The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors | Q33613105 | ||
| IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism | Q33656121 | ||
| Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease. | Q34039427 | ||
| The adaptor TRAF3 restrains the lineage determination of thymic regulatory T cells by modulating signaling via the receptor for IL-2. | Q34071164 | ||
| Analysis of the coding genome of diffuse large B-cell lymphoma | Q34205133 | ||
| IgG1 plasmacytosis in interleukin 6 transgenic mice | Q34308376 | ||
| Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling | Q34340648 | ||
| Impact of interleukin-6 in hematological malignancies | Q34387624 | ||
| TNF receptor-associated factor 3 is required for T cell-mediated immunity and TCR/CD28 signaling | Q34603380 | ||
| The tumor microenvironment is the main source of IL-6 for plasma cell tumor development in mice | Q34861202 | ||
| The effect of the autoimmunity-associated gene, PTPN22, on a BXSB-derived model of lupus | Q34918378 | ||
| The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans | Q35187072 | ||
| An oncogenic role for alternative NF-κB signaling in DLBCL revealed upon deregulated BCL6 expression | Q35588767 | ||
| Regulation of JAK-STAT signalling in the immune system | Q35605437 | ||
| Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors | Q35736556 | ||
| Regulation of plasma-cell development | Q36058417 | ||
| Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT. | Q36058554 | ||
| Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection | Q36073682 | ||
| Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. | Q36155317 | ||
| Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs | Q36156167 | ||
| Specific deletion of TRAF3 in B lymphocytes leads to B-lymphoma development in mice. | Q36208548 | ||
| High affinity germinal center B cells are actively selected into the plasma cell compartment. | Q36228042 | ||
| Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes | Q36403897 | ||
| STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. | Q36677337 | ||
| Protein tyrosine phosphatase function: the substrate perspective | Q36713273 | ||
| A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models | Q36802757 | ||
| The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells | Q37061850 | ||
| Plasma cell development: from B-cell subsets to long-term survival niches. | Q37068273 | ||
| Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma | Q37314736 | ||
| PTPN22 controls the germinal center by influencing the numbers and activity of T follicular helper cells | Q37600124 | ||
| The establishment of the plasma cell survival niche in the bone marrow | Q38070792 | ||
| Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions | Q38179139 | ||
| TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. | Q38293065 | ||
| A Complex Relationship between TRAF3 and Non-Canonical NF-κB2 Activation in B Lymphocytes | Q39037203 | ||
| Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen | Q41694124 | ||
| Interleukin-6 is a growth factor for nonmalignant human plasmablasts. | Q52021179 | ||
| Impaired immune and acute-phase responses in interleukin-6-deficient mice. | Q52514391 | ||
| Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. | Q54167674 | ||
| Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25- and CD25high regulatory T cells. | Q54613582 | ||
| Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas | Q59077136 | ||
| Interleukin-6 is a prognostic factor in multiple myeloma | Q70176421 | ||
| STAT-3 activation by differential cytokines is critical for human in vivo-generated plasma cell survival and Ig secretion | Q86487354 | ||
| P433 | issue | 392 | |
| P304 | page(s) | ra88 | |
| P577 | publication date | 2015-09-01 | |
| P1433 | published in | Science Signaling | Q7433604 |
| P1476 | title | The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development | |
| P478 | volume | 8 |
| Q37465240 | Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells |
| Q41751738 | Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression |
| Q57191736 | Genetic Alterations of TRAF Proteins in Human Cancers |
| Q64106861 | Genetic variants differentially associated with rheumatoid arthritis and systemic lupus erythematosus reveal the disease-specific biology |
| Q39233347 | Protein Tyrosine Phosphatases in Systemic Sclerosis: Potential Pathogenic Players and Therapeutic Targets. |
| Q64990463 | Regulation of Interleukin-6 Receptor Signaling by TNF Receptor-Associated Factor 2 and 5 During Differentiation of Inflammatory CD4+ T Cells. |
| Q58580426 | Role of TRAFs in Signaling Pathways Controlling T Follicular Helper Cell Differentiation and T Cell-Dependent Antibody Responses |
| Q57492396 | TRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation |
| Q38801811 | TRAF3 as a powerful and multitalented regulator of lymphocyte functions. |
| Q41855689 | TRAF3 enhances TCR signaling by regulating the inhibitors Csk and PTPN22. |
| Q90002815 | TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells |
| Q47652771 | TRAF3 regulation of inhibitory signaling pathways in B and T lymphocytes by kinase and phosphatase localization. |
| Q90207982 | The Contribution of PTPN22 to Rheumatic Disease |
| Q91105567 | The cytokine network involved in the host immune response to periodontitis |
| Q89777732 | The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency |
Search more.